vs

Side-by-side financial comparison of NeuroPace Inc (NPCE) and Orange County Bancorp, Inc. (OBT). Click either name above to swap in a different company.

Orange County Bancorp, Inc. is the larger business by last-quarter revenue ($33.0M vs $26.6M, roughly 1.2× NeuroPace Inc). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -10.3%, a 47.9% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 20.6%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 14.3%).

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.

NPCE vs OBT — Head-to-Head

Bigger by revenue
OBT
OBT
1.2× larger
OBT
$33.0M
$26.6M
NPCE
Growing faster (revenue YoY)
NPCE
NPCE
+3.2% gap
NPCE
23.9%
20.6%
OBT
Higher net margin
OBT
OBT
47.9% more per $
OBT
37.6%
-10.3%
NPCE
More free cash flow
OBT
OBT
$40.9M more FCF
OBT
$41.3M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
14.3%
OBT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPCE
NPCE
OBT
OBT
Revenue
$26.6M
$33.0M
Net Profit
$-2.7M
$12.4M
Gross Margin
77.4%
Operating Margin
-6.6%
41.4%
Net Margin
-10.3%
37.6%
Revenue YoY
23.9%
20.6%
Net Profit YoY
48.0%
73.5%
EPS (diluted)
$-0.08
$0.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPCE
NPCE
OBT
OBT
Q4 25
$26.6M
$33.0M
Q3 25
$27.4M
$33.7M
Q2 25
$23.5M
$32.5M
Q1 25
$22.5M
$28.0M
Q4 24
$21.5M
$27.4M
Q3 24
$21.1M
$27.1M
Q2 24
$19.3M
$27.9M
Q1 24
$18.1M
$25.3M
Net Profit
NPCE
NPCE
OBT
OBT
Q4 25
$-2.7M
$12.4M
Q3 25
$-3.5M
$10.0M
Q2 25
$-8.7M
$10.5M
Q1 25
$-6.6M
$8.7M
Q4 24
$-5.3M
$7.2M
Q3 24
$-5.5M
$3.2M
Q2 24
$-7.5M
$8.2M
Q1 24
$-8.9M
$9.3M
Gross Margin
NPCE
NPCE
OBT
OBT
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
NPCE
NPCE
OBT
OBT
Q4 25
-6.6%
41.4%
Q3 25
-9.5%
38.6%
Q2 25
-29.0%
41.9%
Q1 25
-22.9%
40.3%
Q4 24
-17.0%
32.8%
Q3 24
-20.1%
14.8%
Q2 24
-32.4%
36.6%
Q1 24
-41.6%
45.9%
Net Margin
NPCE
NPCE
OBT
OBT
Q4 25
-10.3%
37.6%
Q3 25
-12.8%
29.7%
Q2 25
-36.8%
32.2%
Q1 25
-29.3%
31.1%
Q4 24
-24.5%
26.2%
Q3 24
-25.9%
11.8%
Q2 24
-39.0%
29.4%
Q1 24
-49.2%
36.7%
EPS (diluted)
NPCE
NPCE
OBT
OBT
Q4 25
$-0.08
$0.94
Q3 25
$-0.11
$0.75
Q2 25
$-0.26
$0.87
Q1 25
$-0.21
$0.77
Q4 24
$-0.16
$0.64
Q3 24
$-0.19
$0.28
Q2 24
$-0.26
$0.73
Q1 24
$-0.32
$0.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPCE
NPCE
OBT
OBT
Cash + ST InvestmentsLiquidity on hand
$61.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$19.0M
$284.4M
Total Assets
$105.6M
$2.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPCE
NPCE
OBT
OBT
Q4 25
$61.1M
Q3 25
$60.0M
Q2 25
$62.1M
Q1 25
$66.3M
Q4 24
$52.8M
Q3 24
$56.8M
Q2 24
$55.5M
Q1 24
$58.9M
Stockholders' Equity
NPCE
NPCE
OBT
OBT
Q4 25
$19.0M
$284.4M
Q3 25
$18.5M
$270.1M
Q2 25
$19.4M
$252.6M
Q1 25
$24.3M
$201.3M
Q4 24
$8.0M
$185.5M
Q3 24
$9.8M
$193.1M
Q2 24
$9.9M
$177.5M
Q1 24
$14.3M
$168.7M
Total Assets
NPCE
NPCE
OBT
OBT
Q4 25
$105.6M
$2.7B
Q3 25
$107.3M
$2.6B
Q2 25
$106.1M
$2.6B
Q1 25
$110.2M
$2.6B
Q4 24
$94.6M
$2.5B
Q3 24
$96.3M
$2.5B
Q2 24
$94.4M
$2.5B
Q1 24
$98.9M
$2.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPCE
NPCE
OBT
OBT
Operating Cash FlowLast quarter
$506.0K
$43.8M
Free Cash FlowOCF − Capex
$409.0K
$41.3M
FCF MarginFCF / Revenue
1.5%
125.1%
Capex IntensityCapex / Revenue
0.4%
7.6%
Cash ConversionOCF / Net Profit
3.53×
TTM Free Cash FlowTrailing 4 quarters
$-11.3M
$69.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPCE
NPCE
OBT
OBT
Q4 25
$506.0K
$43.8M
Q3 25
$-1.9M
$30.2M
Q2 25
$-2.1M
$-5.0M
Q1 25
$-7.5M
$4.8M
Q4 24
$-4.8M
$34.6M
Q3 24
$-1.7M
$10.2M
Q2 24
$-3.9M
$9.3M
Q1 24
$-7.5M
$2.3M
Free Cash Flow
NPCE
NPCE
OBT
OBT
Q4 25
$409.0K
$41.3M
Q3 25
$-2.0M
$29.6M
Q2 25
$-2.3M
$-5.7M
Q1 25
$-7.5M
$4.3M
Q4 24
$-4.8M
$32.9M
Q3 24
$-1.8M
$10.0M
Q2 24
$-4.0M
$9.2M
Q1 24
$-7.6M
$2.0M
FCF Margin
NPCE
NPCE
OBT
OBT
Q4 25
1.5%
125.1%
Q3 25
-7.2%
87.8%
Q2 25
-9.6%
-17.5%
Q1 25
-33.4%
15.5%
Q4 24
-22.5%
120.0%
Q3 24
-8.7%
36.7%
Q2 24
-20.6%
32.8%
Q1 24
-42.1%
7.9%
Capex Intensity
NPCE
NPCE
OBT
OBT
Q4 25
0.4%
7.6%
Q3 25
0.1%
1.8%
Q2 25
0.7%
2.3%
Q1 25
0.2%
1.8%
Q4 24
0.2%
6.3%
Q3 24
0.5%
1.1%
Q2 24
0.3%
0.4%
Q1 24
0.6%
1.0%
Cash Conversion
NPCE
NPCE
OBT
OBT
Q4 25
3.53×
Q3 25
3.01×
Q2 25
-0.47×
Q1 25
0.56×
Q4 24
4.83×
Q3 24
3.19×
Q2 24
1.13×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons